COMMUNIQUÉS West-GlobeNewswire

Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.
15/09/2025
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc. Mont-Saint-Guibert, Belgique – 15 septembre 2025, 22h10 CET / 16h10 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH [...]
Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
15/09/2025
From menopause to menstruation and beyond, Vital Talks bring vital science to women at every stage of their health journey TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) is proud to [...]
L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires
15/09/2025
De la ménopause aux menstruations et plus encore, Conversations vitales fournit des renseignements scientifiques importants aux femmes à chaque étape de leur parcours de santé TORONTO, 15 sept. 2025 (GLOBE NEWSWIRE) -- [...]
AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction
15/09/2025
NORTH KINGSTOWN, Rhode Island, Sept. 15, 2025 (GLOBE NEWSWIRE) -- AdCare Rhode Island has appointed Nicole Paliotti as its new Executive Director. As a trusted healthcare leader who has served the Rhode Island community [...]
HNL Lab Medicine Receives Accreditation from College of American Pathologists
15/09/2025
ALLENTOWN, Pa., Sept. 15, 2025 (GLOBE NEWSWIRE) -- The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to HNL Lab Medicine Acute Care Labs located in Macungie and [...]
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
15/09/2025
Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG on track to initiate by year-end 2025 [...]

Pages